Research article
Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients
-
* Corresponding author: Galatea Kallergi kalergi@med.uoc.gr
1 Laboratory of Tumor Cell Biology, School of Medicine, University of Crete, Voutes, Heraklion, 71110, Greece
2 Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, 15771, Greece
3 Department of Medical Oncology, University General Hospital of Heraklion, Voutes, Heraklion, 71110, Greece
Breast Cancer Research 2009, 11:R84 doi:10.1186/bcr2452
Published: 17 November 2009Additional files
Additional file 1:
A table listing the number of VEGF, VEGFR2 and HIF-1α-positive CTCs in patients with breast cancer. It is named as Supplementary Table S1.
Format: DOC Size: 35KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 2:
A table listing the antibodies and the corresponding dilutions utilized in the present study. It is named as Supplementary Table S2.
Format: DOC Size: 24KB Download file
This file can be viewed with: Microsoft Word Viewer
Additional file 3:
A diagram presenting the quantification of VEGF, VEGFR2, HIF-1α and pFAK expression in breast cancer cell lines. It is named as Supplementary diagram.
Format: DOC Size: 31KB Download file
This file can be viewed with: Microsoft Word Viewer